Shareholder Votes

Caesars Entertainment, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm The shareholders approved the ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The number and type of votes cast with respect to the proposal were as follows: Votes For % Voted Votes Against % Voted Abstentions Broker Non-Votes 178,889,019 99.8 % 317,670 0.2 % 93,908 — The foregoing Proposal 3 was approved.”

Caesars Entertainment, Inc. shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-06-09 meeting.

“Proposal 2: Advisory Vote to Approve Named Executive Officer Compensation The shareholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the Company’s Proxy Statement. The number and type of votes cast with respect to the proposal, as well as the number of broker non-votes with respect to the proposal, were as follows: Votes For % Voted Votes Against % Voted Abstentions Broker Non-Votes 134,624,250 85.7 % 22,548,056 14.3 % 80,430 22,047,861 The foregoing Proposal 2 was approved.”

Caesars Entertainment, Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Proposal 1: Election of Directors The shareholders elected the Company’s nominees to the Board. The nominees for election to the Board, the number and type of votes cast with respect to each nominee, as well as the number of broker non-votes with respect to each nominee, were as follows: Nominee Votes For % Voted Votes Against % Voted Abstentions Broker Non-Votes Gary L. Carano 153,654,389 97.7 % 3,541,728 2.3 % 56,619 22,047,861 Bonnie S. Biumi 155,167,075 98.7 % 2,007,368 1.3 % 78,293 22,047,861 Jan Jones Blackhurst 155,078,470 98.7 % 2,097,106 1.3 % 77,160 22,047,861 Frank J. Fahrenkopf, Jr. 138,676,487 88.2 % 18,505,815 11.8 % 70,434 22,047,861 Kim Harris Jones 155,542,635 98.9 % 1,652,800 1.1 % 57,301 22,047,861 Jesse Lynn 156,714,584 99.7 % 479,603 0.3 % 58,549 22,047,861 Courtney R. Mather 156,207,893 99.4 % 987,563 0.6 % 57,280 22,047,861 Ted Papapostolou 151,977,304 96.7 % 5,214,008 3.3 % 61,424 22,047,861 Michael E. Pegram 155,779,341 99.1 % 1,415,744 0.9 % 57,651 22,047,861”

DoorDash, Inc. shareholders approved Advisory vote on compensation of named executive officers. at the 2026-06-10 meeting.

“3. Advisory Vote on Compensation of Named Executive Officers For Against Abstain Broker Non-Votes 801,393,913 28,919,623 131,278 26,934,621 Based on the votes set forth above, the stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers.”

DoorDash, Inc. shareholders approved Ratification of appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-10 meeting.

“2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstain 855,145,819 2,121,211 112,405 Based on the votes set forth above, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

DoorDash, Inc. shareholders approved Election of four Class III directors to serve until the 2029 annual meeting and until their successors are duly elected and qualified. at the 2026-06-10 meeting.

“1. Election of Directors Nominee For Against Abstain Broker Non-Votes Shona L. Brown 745,895,048 84,442,121 107,645 26,934,621 Milan Kovac 804,527,520 25,543,955 373,339 26,934,621 Alfred Lin 778,605,856 51,744,572 94,386 26,934,621 Stanley Tang 779,909,106 50,131,215 404,493 26,934,621 Based on the votes set forth above, each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified.”

Ares Management Corp shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-06-08 meeting.

“The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year was approved based on the following votes:”

Ares Management Corp shareholders approved Election of Directors at the 2026-06-08 meeting.

“The nominees listed below were elected as directors of the Company to serve for one-year terms expiring at the 2027 Annual Meeting of Stockholders once their respective successors have been duly elected and qualified or until their earlier resignation or removal, based on the following votes:”

PALISADE BIO, INC. shareholders approved Approval of equity award grants to our non-employee directors at the 2026-06-10 meeting.

“The Company’s stockholders approved equity grants to the Company’s non-employee directors.”

PALISADE BIO, INC. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-10 meeting.

“The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement.”

PALISADE BIO, INC. shareholders approved Approval of the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan at the 2026-06-10 meeting.

“The Company’s stockholders approved the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan.”

PALISADE BIO, INC. shareholders approved Approval of the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan at the 2026-06-10 meeting.

“The Company’s stockholders approved the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan.”

PALISADE BIO, INC. shareholders approved Approval of an Amendment to the Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock at the 2026-06-10 meeting.

“The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 450,000,000 (which will result in an increase in the total number of authorized shares of capital stock of the Company from 307,000,000 to 457,000,000).”

PALISADE BIO, INC. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“The Company’s stockholders ratified the selection of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

PALISADE BIO, INC. shareholders approved Election of Directors at the 2026-06-10 meeting.

“The Company’s stockholders elected the four (4) persons listed below as directors, each to serve until the Company’s 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal.”

Ocugen, Inc. shareholders approved Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“(d) Proposal 4 - Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers . The stockholders voted to approve, on an advisory basis, a preferred frequency of “one year” for future advisory votes on the compensation of the Company’s named executive officers, as follows: Votes For 1 Year Votes For 2 Years Votes For 3 Years Abstentions Broker Non-Votes 57,545,540 1,584,772 3,520,522 2,068,327 74,908,914”

Ocugen, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“(c) Proposal 3 - Approval, on an advisory basis, of the compensation of the Company’s named executive officers. The stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers, as follows: Votes For Votes Against Abstentions Broker Non-Votes 49,968,948 13,245,090 1,505,123 74,908,914”

Ocugen, Inc. shareholders approved Ratification of Independent Registered Public Accountant at the 2026-06-11 meeting.

“(b) Proposal 2 - Ratification of Independent Registered Public Accountant . The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year, as follows: Votes For Votes Against Abstentions Broker Non-Votes 136,784,245 1,002,550 1,841,280 -”

Ocugen, Inc. shareholders approved Election of Two Class III Directors at the 2026-06-11 meeting.

“On June 11, 2026, Ocugen, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") virtually at 8:00 a.m. ET. At the Annual Meeting, a total of 139,628,075 shares of the Common Stock were represented virtually or by proxy. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting on June 11, 2026: (a) Proposal 1 - Election of Two Class III Directors. The stockholders elected Kirsten Castillo, MBA, and Satish Chandran, Ph.D. to the Board of Directors of the Company (the "Board") to serve as a director until the 2029 Annual Meeting of Stockholders and until their respective successor, if any, is elected and qualified, or until their earlier death, resignation, retirement, disqualification, or other removal, as follows: Name For Withheld Broker Non-Votes Kirsten Castillo, MBA 56,242,944 8,476,217 74,908,914 Satish Chandran, Ph.D. 62,604,983 2,114,178 74,908,914”

Immuneering Corp shareholders approved Ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-11 meeting.

“Item 2 — Ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 42,142,848 1,920,218 431,993 0”

Immuneering Corp shareholders approved Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders at the 2026-06-11 meeting.

“Item 1 — Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes AGAINST Votes WITHHELD Broker Non-Votes Peter Feinberg 26,420,287 0 2,008,073 16,066,699 Laurie B. Keating 27,121,501 0 1,306,859 16,066,699”

U.S. GoldMining Inc. shareholders approved Ratification of the appointment of Deloitte LLP, Chartered Professional Accountants, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“2. Ratification of the appointment of Deloitte LLP, Chartered Professional Accountants, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 11,600,542 56,132 2,705”

U.S. GoldMining Inc. shareholders approved Election of the six directors at the 2026-06-11 meeting.

“The matters described below were submitted to a vote of the holders of the Company’s Common Stock at the Annual Meeting. Each proposal is described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 30, 2026 (the “Proxy Statement”). 1. Election of the six directors, each to serve until the next annual meeting of stockholders and until his or her successor is duly elected or qualified, or such director’s earlier death, resignation, or removal. Nominee For Withhold Authority Broker Non-Votes Alastair Still 10,843,315 9,783 806,281 Garnet Dawson 10,777,523 75,575 806,281 Ross Sherlock 10,835,246 17,852 806,281 Lisa Wade 10,829,910 23,188 806,281 Laura Schmidt 10,728,982 124,116 806,281 Aleksandra Bukacheva 10,830,017 23,081 806,281 2. Ratification of the appointment of Deloitte LLP, Chartered Professional Accountants, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Light & Wonder, Inc. shareholders approved Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 5: Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 For Against Abstain 50,325,283 3,530,235 163,174”

Light & Wonder, Inc. shareholders approved Approval of the Aggregate Annual Amount that May Be Paid or Granted as the Company’s Non-Employee Director Compensation (Cash and Equity) Pursuant to and in Accordance with ASX Listing Rule 10.17 at the 2026-06-10 meeting.

“Proposal 4: Approval of the Aggregate Annual Amount that May Be Paid or Granted as the Company’s Non-Employee Director Compensation (Cash and Equity) Pursuant to and in Accordance with ASX Listing Rule 10.17 For Against Abstain Broker Non-Votes 41,382,945 10,484,486 177,790 1,879,973”

Light & Wonder, Inc. shareholders approved Approval of 2026 Long-Term Incentive Equity Grants to the Company’s Director-CEO Pursuant to and in Accordance with ASX Listing Rule 10.14 at the 2026-06-10 meeting.

“Proposal 3: Approval of 2026 Long-Term Incentive Equity Grants to the Company’s Director-CEO Pursuant to and in Accordance with ASX Listing Rule 10.14 For Against Abstain Broker Non-Votes 48,066,016 3,904,727 167,976 1,879,973”

Light & Wonder, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-06-10 meeting.

“Proposal 2: Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 48,053,880 3,941,357 143,482 1,879,973”

Light & Wonder, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1: Election of Directors For Withheld Broker Non-Votes Jamie R. Odell 50,002,185 2,136,534 1,879,973 Matthew R. Wilson 51,916,607 222,112 1,879,973 Antonia Korsanos 50,961,176 1,177,543 1,879,973 Michael Marchetti 51,912,647 226,072 1,879,973 Hamish R. McLennan 45,552,916 6,585,803 1,879,973 Stephen Morro 51,913,623 225,096 1,879,973 Virginia E. Shanks 51,917,023 221,696 1,879,973 Timothy Throsby 51,844,937 293,782 1,879,973 Kneeland C. Youngblood 46,817,488 5,321,231 1,879,973”

FRACTYL HEALTH, INC. shareholders approved Ratification of Independent Auditors at the 2026-06-10 meeting.

“For Against Abstain 107,931,959 189,715 4,114,532”

FRACTYL HEALTH, INC. shareholders approved Election of Class II Directors at the 2026-06-10 meeting.

“Director Nominee For Withheld Broker Non-Vote Marc Elia 65,196,683 9,029,601 38,009,922 Clive Meanwell, M.B., Ch.B., M.D. 63,701,054 10,525,230 38,009,922 Ian Sheffield 73,761,318 464,966 38,009,922”

Seritage Growth Properties shareholders rejected Approval of an advisory, non-binding, resolution to approve the Company’s executive compensation program for the Company’s named executive officers at the 2026-06-09 meeting.

“The shareholders rejected an advisory, non-binding, resolution to approve the Company’s executive compensation program for the Company’s named executive officers.”

Seritage Growth Properties shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-06-09 meeting.

“The shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026.”

Seritage Growth Properties shareholders voted on Election of trustees: John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann at the 2026-06-09 meeting.

“John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann stood for re-election as trustees of the Company for a term ending at the 2027 annual meeting of shareholders.”

Quince Therapeutics, Inc. shareholders approved Adjournment of Annual Meeting to permit further solicitation and vote of proxies if necessary at the 2026-06-11 meeting.

“The Company’s stockholders approved the adjournment or postponement of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in favor of the foregoing proposals.”

Quince Therapeutics, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2026-06-11 meeting.

“The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement.”

Quince Therapeutics, Inc. shareholders approved Ratification of Selection of Independent Registered Accounting Firm BDO USA, P.C. for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“The Company’s stockholders ratified the selection of BDO USA, P.C. as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2026.”

Quince Therapeutics, Inc. shareholders approved Approval of Amendment to the Certificate of Incorporation to Effect a Reverse Stock Split at a ratio ranging from one-for-ten to one-for-one hundred at the 2026-06-11 meeting.

“The Company’s stockholders approved the amendment to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio ranging from one-for-ten (1-for-10) to one-for-one hundred (1-for-100) with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors in its sole discretion.”

Quince Therapeutics, Inc. shareholders approved Election of one Class I director to serve until the 2029 annual meeting at the 2026-06-11 meeting.

“The Company’s stockholders approved the election of one Class I director to the Board of Directors to serve until the 2029 annual meeting of stockholders and until her successor is duly elected and qualified or until her earlier death, resignation, disqualification or removal.”

Coursera, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-10 meeting.

“Proposal 3 : The appointment of Deloitte & Touche LLP as Coursera’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. The voting results were as follows: For Against Abstain 131,826,645 1,820,667 96,111”

Coursera, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2026-06-10 meeting.

“Proposal 2 : The compensation paid by Coursera to its named executive officers as disclosed in the Proxy Statement was approved, on a non-binding advisory basis. The voting results were as follows: For Against Abstain Broker Non-Votes 100,729,503 13,960,373 133,038 18,920,509”

Coursera, Inc. shareholders approved Election of Class II directors at the 2026-06-10 meeting.

“Proposal 1 : The following nominees were elected to serve as Class II directors on Coursera’s Board of Directors until Coursera's 2029 annual meeting of stockholders or until their successors are duly elected and qualified. The voting results were as follows: For Withheld Broker Non-Votes Christopher D. McCarthy 96,895,428 17,927,486 18,920,509 Andrew Y. Ng 98,840,457 15,982,457 18,920,509 Lydia Paterson 114,504,109 318,805 18,920,509”

Planet 13 Holdings Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm Davidson & Company LLP for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Our shareholders ratified the appointment of Davidson & Company LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Planet 13 Holdings Inc. shareholders approved Amendment to Planet 13 Holdings Inc.'s 2023 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder from 32,000,000 to 52,000,000 at the 2026-06-10 meeting.

“Our shareholders approved the amendment to Planet 13 Holdings Inc.’s 2023 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder from 32,000,000 to 52,000,000.”

Planet 13 Holdings Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Our shareholder elected the following directors to serve until the close of business of the next annual meeting of the Company’s shareholders or until such director’s successor has been duly elected and qualified.”

Nkarta, Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation at the 2026-06-10 meeting.

“The stockholders voted, on a non-binding, advisory basis, on the frequency of future advisory votes on the compensation paid to the Company’s named executive officers. The voting results were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 34,447,256 21,461 4,565,940 354,355 6,934,994”

Nkarta, Inc. shareholders approved Advisory Approval of the Compensation Paid to the Company’s Named Executive Officers at the 2026-06-10 meeting.

“The stockholders approved, on a non- binding, advisory basis, the compensation paid to the Company’s named executive officers. The voting results were as follows: For Against Abstain Broker Non-Votes 43,493,065 3,313,424 38,722 6,934,994”

Nkarta, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP at the 2026-06-10 meeting.

“The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: For Against Abstain Broker Non-Votes 53,684,352 76,073 19,780 —”

Nkarta, Inc. shareholders approved Election of Class III directors at the 2026-06-10 meeting.

“The stockholders elected the following two Class III directors to serve until the Company’s 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified. The voting results were as follows: For Withheld Broker Non-Votes Ali Behbahani, M.D., M.B.A. 32,285,680 14,559,531 6,934,994 Zachary Scheiner, Ph.D. 37,313,469 9,531,742 6,934,994”

Ategrity Specialty Insurance Co Holdings shareholders approved Ratification of the appointment of EY as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“The stockholders ratified the appointment of EY as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Ategrity Specialty Insurance Co Holdings shareholders approved Election of seven directors to serve until the 2027 annual meeting at the 2026-06-09 meeting.

“The stockholders elected each of the seven persons named below as directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified.”